Ecolab(ECL) - 2025 Q2 - Quarterly Results
EcolabEcolab(US:ECL)2025-07-29 12:11

Financial Performance - Reported diluted EPS was $1.84, an increase of 8%, while adjusted diluted EPS was $1.89, up 13% compared to the previous year[3] - Net sales for the second quarter were $4.0 billion, reflecting a 1% increase, with organic sales growing by 3%[3] - Operating income increased by 8% to $710.1 million, with an organic operating income increase of 14%[7] - Ecolab reported net sales of $4,025.2 million for Q2 2025, a 1% increase from $3,985.8 million in Q2 2024[44] - The company's operating income for Q2 2025 was $710.1 million, reflecting an 8% increase compared to $656.9 million in Q2 2024[44] - Net income attributable to Ecolab for Q2 2025 was $524.2 million, up 7% from $490.9 million in Q2 2024[44] - Diluted earnings per share increased by 8% to $1.84 in Q2 2025, compared to $1.71 in Q2 2024[44] - Non-GAAP adjusted operating income for the second quarter of 2025 was $737.2 million, an increase of 10% from $669.8 million in 2024[56] - Adjusted diluted earnings per share for Q2 2025 is projected at $1.89, compared to $1.68 in Q2 2024, reflecting a growth of 12.5%[61] Segment Performance - The Global Water segment reported sales of $1.91 billion, a 2% increase, with an organic operating income margin of 16.1%[12] - The Global Institutional & Specialty segment achieved organic sales growth of 4%, with operating income increasing by 16%[17] - The Global Life Sciences segment saw a 4% increase in sales, with operating income surging by 105%[19] - Global Water segment reported net sales of $1,908.5 million, a 2% increase from $1,863.2 million in the same quarter of 2024[47] - Global Life Sciences segment operating income surged by 105% to $34.8 million, compared to $17.0 million in the second quarter of 2024[47] - Global Pest Elimination segment net sales increased by 7% to $311.3 million, compared to $290.2 million in the second quarter of 2024[47] - Operating income for the Global Institutional & Specialty segment was $359.4 million in Q2 2025, compared to $329.5 million in Q2 2024, representing an increase of 9.1%[59] - The Global Pest Elimination segment achieved net sales of $311.3 million in Q2 2025, a 7.3% increase from $290.2 million in Q2 2024[59] Future Outlook - The company maintains its 2025 adjusted diluted EPS outlook in the range of $7.42 to $7.62, representing a growth of 12% to 15%[3] - Ecolab expects third quarter 2025 adjusted diluted EPS in the range of $2.02 to $2.12, reflecting a growth of 10% to 16% compared to the previous year[25] - The company anticipates continued growth in net sales and operating income for the remainder of 2025, driven by strategic market expansions and new product developments[59] Shareholder Actions - The company repurchased approximately 150,000 shares of its common stock during the second quarter[11] Financial Position - Total current assets increased to $7,075.8 million as of June 30, 2025, up from $6,025.7 million at the end of 2024[52] - Total liabilities rose to $14,385.4 million as of June 30, 2025, compared to $13,598.6 million at the end of 2024[52] - The company’s total assets reached $23,736.0 million as of June 30, 2025, up from $22,387.8 million at the end of 2024[52] Cost and Expenses - The cost of sales decreased by 1% to $2,222.8 million in Q2 2025 from $2,241.0 million in Q2 2024[44] - Interest expense decreased by 20% to $63.2 million in Q2 2025, down from $78.8 million in Q2 2024[44] - Special (gains) and charges for Q2 2025 totaled $24.6 million, compared to $12.2 million in Q2 2024[44] - Special gains and charges for Q2 2025 amounted to $26.7 million, compared to $12.8 million in Q2 2024, indicating a significant increase[59] Currency Impact - Currency impact contributed an additional $117.0 million to net sales in Q2 2025, compared to $114.5 million in Q2 2024[59]